GE Healthcare Technologies (GEHC) has been a significant focus of financial news, with various institutional investors making notable purchases of shares. Specifically,
Vontobel Holding Ltd added 17,145 shares to their holdings, while
Seven Grand Managers LLC grew their stock positions.
Stonegate Investment Group LLC further purchased 9,572 shares, and
Sound Shore Management Inc acquired a significant 230,906 shares. The company's stock is primarily institutionally owned, at around 75%. In product news, GEHC launched their
Versana Premier multi-purpose ultrasound system and partnered with the
University Medicine Essen to accelerate Theranostics and personalized medicine. Their AI-powered
Venue Sprint received positive attention upon its launch. Despite a few set backs including weakness in the Chinese market resulting in missed quarterly revenue estimates and a subsequent guidance cut, GEHC bounced back with a Q2 earnings beat, increased net margin, and approval for Flyrcado by the FDA. Notably, financial commentator
Jim Cramer expressed positive sentiments on the stock, suggesting it's just starting to gain momentum.
Ge Healthcare Technologies GEHC News Analytics from Tue, 13 Feb 2024 08:00:00 GMT to Sat, 19 Oct 2024 18:17:04 GMT -
Rating 6
- Innovation 7
- Information 8
- Rumor -2
